Our Analytical Development team is growing and we’re seeking a Senior Research Associate to participate in designing and executing experiments, as well as perform sample analysis utilizing HPLC, CE-SDS, iCIEF, and plate-based assays. These activities will support CMC, discovery, pre-clinical, and clinical development of existing and new lead candidates. This position will directly support the discovery of next-generation immune oncology drugs. It is a hands-on position that requires effective communication and documentation of results to enable the advancement of novel research molecules toward development of clinical candidates, which will ultimately lead to late-stage development and commercialization. Ideal applicants will be agile and highly driven, collaborative, team-oriented, possess excellent communication and organization skills, and carry a strong commitment to excellence.
ESSENTIAL FUNCTIONS AND RESPONSIBILITIES
- Perform HPLC and UPLC assays with minimal supervision including SEC and RP.
- Execute CE-SDS and iCIEF analysis for novel protein therapeutics and contribute to method optimization, qualification, and lifecycle management.
- Perform ELISAs for potency assessment.
- Perform DLS/SLS analysis using an UNcle instrument and generate datasets that will be used for formulation development studies.
- Perform subvisible particulate matter analysis by HIAC.
- Perform formulation development studies and execute clinical in-use stability studies, transfer formulation knowledge internally.
- Design, conduct, analyze, interpret, and report laboratory experiments; summarize results for meetings and regulatory filings.
- Write and manage SOP’s and test methods.
- Manage and maintain required reagents, laboratory environment, and equipment needed to carry out assignments.
- Draft development reports, method qualification protocols, and method qualification reports
- Prepare presentations for team meetings.
- Work closely with team leaders to complete highest priority work to reach goals and milestones.
- Other duties as assigned.
REQUIRED SKILLS AND QUALIFICATIONS
- Bachelor’s degree and 4-6 years of relevant industry experience or a master’s degree with 3-5 years of relevant industry experience.
- Strong benchtop skills, experience with analysis of protein biologics and peptides.
- Proficiency with HPLC and UPLC assays; at least 3 years of experience is required. SEC and RP are desired.
- Experience with protein characterization techniques including CE-SDS, iCIEF, or related electrophoretic methods is preferred.
- Experience performing ELISAs is desired but not necessary
- Experience supporting analytical method qualification, comparability, stability, or formulation development studies is preferred.
- Demonstrated ability to analyze complex datasets, identify trends, troubleshoot experiments, and communicate scientific conclusions effectively.
- Ability to perform routine testing and to follow SOPs in a highly accurate and reproducible manner.
- Desire and ability to learn new technologies and explore new approaches to innovate.
- Training on project specific assays and ability to train others.
- Proven experience with writing and maintaining SOPs.
- Demonstrated ability to maintain accurate, complete, and contemporaneous experimental records in ELN systems in accordance with Good Documentation Practices (GDP).
- Ability to work independently; anticipates and solves problems in a proactive fashion.
- Must have excellent computer skills, and proficiency with Microsoft Excel and PowerPoint are required.
- Good oral and written communication skills a must.
- Excellent team player.
Skills Required
- Bachelor’s degree with 4–6 years of relevant industry experience, or master’s degree with 3–5 years of relevant industry experience.
- Strong benchtop skills and experience analyzing protein biologics and peptides.
- At least 3 years of experience with HPLC and UPLC assays.
- Experience with SEC and RP assays.
- Experience with protein characterization techniques including CE-SDS, iCIEF, or related electrophoretic methods.
- Experience performing ELISAs.
- Experience supporting analytical method qualification, comparability, stability, or formulation development studies.
- Ability to analyze complex datasets, identify trends, troubleshoot experiments, and communicate scientific conclusions.
- Ability to perform routine testing and follow SOPs accurately and reproducibly.
- Ability and willingness to learn new technologies and explore innovative approaches.
- Ability to train others on project-specific assays.
- Experience writing and maintaining SOPs.
- Experience maintaining accurate experimental records in ELN systems according to Good Documentation Practices.
- Ability to work independently and solve problems proactively.
- Proficiency with Microsoft Excel and Microsoft PowerPoint.
- Strong oral and written communication skills.
- Ability to work effectively as a team member.
- United States work authorization.
What We Do
Janux Therapeutics is an innovative biopharmaceutical company developing next-generation therapeutics based on its proprietary Tumor Activated T Cell Engager (TRACTr) platform technology to better treat patients suffering from cancer. Janux’s initial focus is on developing a novel class of T cell engagers (TCEs), and its lead product candidates are designed to target clinically validated drug targets. While TCE therapeutics have displayed potent anti-tumor activity in hematological cancers, developing TCEs to treat solid tumors have faced challenges due to the limitations of prior TCE technologies, namely (i) overactivation of the immune system leading to cytokine release syndrome, (ii) on-target, healthy tissue toxicities, and (iii) poor pharmacokinetics leading to short half-life. Janux is using its TRACTr platform technology to engineer product candidates designed to overcome these limitations. Janux is developing a broad pipeline with lead programs targeting prostate-specific membrane antigen (PSMA), epidermal growth factor receptor (EGFR), and trophoblast cell surface antigen 2 (TROP2), with all of its programs currently in the IND-enabling or discovery stage.
.png)






